Scientists have found that ADHD (Attention-Deficit/Hyperactivity Disorder) in women is diagnosed approximately five years ...

Can Pfizer’s GDF15-blocking, appetite-boosting antibody ponsegromab address a cancer-induced wasting syndrome — and help ...

To mark Fragile X awareness day today and the 35th anniversary of the Fragile X Society, Queen’s University and the Fragile X ...

Hayden Eastbury lives with fragile X syndrome. He dreams of working for the ABC one day and has made it his mission to visit them all.

The medical establishment and mainstream media are uniting against the Trump administration's re-purposing of an inexpensive drug to treat an epidemic, calling it "unproven," not "backed by science," ...

Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced topline results from its Phase 3 registrational clinical trial (the RECONNECT Study) of ...

Sept 24 (Reuters) - Harmony Biosciences (HRMY.O), opens new tab said on Wednesday its experimental drug for a rare genetic disorder failed to meet the main goal in a late-stage trial, sending its ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Harmony Biosciences faces a ...

1 Child and Adolescent Neuropsychiatry Unit, Bambino Gesù Children’s Hospital, IRCCS, Rome, Italy 2 Life Sciences and Public Health Department, Catholic University, Rome, Italy Introduction: Emotion ...

A study involving more than half a million adults has confirmed that the combination of cardiovascular, kidney, and metabolic conditions, collectively known as cardiovascular–kidney–metabolic (CKM) ...